In the wake of the U.S. government ordering the Chinese artificial intelligence company iCarbonX to divest its majority ownership stake in the Cambridge, Mass.-based company PatientsLikeMe, Eric Topol, M.D., of Scripps Research, argues for more, not less, collaboration between China and the U.S. on artificial intelligence development.

Source link